Keros Therapeutics, Inc. — SC 13G Filings
7 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Keros Therapeutics, Inc. (KROS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Keros Therapeutics, Inc. has filed 7 SC 13G documents with the SEC since 2016. To view all SEC filings by Keros Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS EX
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | SC 13G | 0001178913-22-001487 | Apr 11, 2022 | — |
| SC 13G | — | 0001172661-21-002445 | Dec 30, 2021 | — |
| SC 13G | SC 13G | 0001104659-21-019848 | Feb 10, 2021 | — |
| SC 13G | — | 0000834237-21-007043 | Feb 2, 2021 | — |
| SC 13G | — | 0000315066-20-001907 | Nov 10, 2020 | — |
| SC 13G | — | 0000935836-20-000488 | Aug 31, 2020 | — |
| SC 13G | SC 13G | 0001104659-20-046925 | Apr 15, 2020 | — |